* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 2064 | ERBB2 | C1458155 | Mammary Neoplasms | 0.369628114093152 | BEFREE;CTD_human;GAD;LHGDN |
| 2064 | ERBB2 | C0027627 | Neoplasm Metastasis | 0.33127356894841 | BEFREE;CTD_human;GAD;LHGDN |
| 2064 | ERBB2 | C0001418 | Adenocarcinoma | 0.301983033067515 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0699791 | Stomach Carcinoma | 0.28 | BEFREE;HPO |
| 2064 | ERBB2 | C0596263 | Carcinogenesis | 0.255220083626833 | BEFREE;CTD_human |
| 2064 | ERBB2 | C0919267 | ovarian neoplasm | 0.241340190643006 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0006142 | Malignant neoplasm of breast | 0.24 | BEFREE;GAD;MGD |
| 2064 | ERBB2 | C0024121 | Lung Neoplasms | 0.234182938876148 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0033578 | Prostatic Neoplasms | 0.233633485307722 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0038356 | Stomach Neoplasms | 0.224610567560641 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0206698 | Cholangiocarcinoma | 0.211220732020785 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0017638 | Glioma | 0.211169574863473 | BEFREE;CTD_human;GAD;LHGDN |
| 2064 | ERBB2 | C0017636 | Glioblastoma | 0.207403267796436 | BEFREE;HPO;LHGDN |
| 2064 | ERBB2 | C0024667 | Animal Mammary Neoplasms | 0.207221085569864 | CTD_human;GAD |
| 2064 | ERBB2 | C0014859 | Esophageal Neoplasms | 0.206802657070698 | BEFREE;CTD_human;GAD |
| 2064 | ERBB2 | C0025149 | Medulloblastoma | 0.204381273170092 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0007134 | Renal Cell Carcinoma | 0.204120901763196 | BEFREE;CTD_human |
| 2064 | ERBB2 | C0009375 | Colonic Neoplasms | 0.203831819601666 | BEFREE;CTD_human;LHGDN |
| 2064 | ERBB2 | C0027659 | Neoplasms, Experimental | 0.202407028523288 | CTD_human;GAD |
| 2064 | ERBB2 | C1621958 | Glioblastoma Multiforme | 0.201373633921065 | BEFREE;HPO |
| 2064 | ERBB2 | C0030354 | Papilloma | 0.200824180352639 | BEFREE;CTD_human |
| 2064 | ERBB2 | C0007120 | Bronchioloalveolar Adenocarcinoma | 0.200549453568426 | BEFREE;HPO |
| 2064 | ERBB2 | C2931822 | Nasopharyngeal carcinoma | 0.200549453568426 | BEFREE;CTD_human |
| 2064 | ERBB2 | C0024232 | Lymphatic Metastasis | 0.200549453568426 | BEFREE;CTD_human |
| 2064 | ERBB2 | C0017185 | Gastrointestinal Neoplasms | 0.200274726784213 | BEFREE;CTD_human |
| 2064 | ERBB2 | C0007117 | Basal cell carcinoma | 0.2 | CTD_human |
| 2064 | ERBB2 | C0014474 | Ependymoma | 0.2 | HPO |
| 2064 | ERBB2 | C0016978 | gallbladder neoplasm | 0.2 | CTD_human |
| 2064 | ERBB2 | C4020899 | Autosomal recessive predisposition | 0.2 | HPO |
| 2064 | ERBB2 | C0024668 | Mammary Neoplasms, Experimental | 0.2 | CTD_human |
| 2064 | ERBB2 | C0027643 | Neoplasm Recurrence, Local | 0.2 | CTD_human |
| 2064 | ERBB2 | C0544886 | Somatic mutation | 0.2 | HPO |
| 2064 | ERBB2 | C0678222 | Breast Carcinoma | 0.08 | BEFREE |
| 2064 | ERBB2 | C0751922 | Median Neuropathy | 0.08 | RGD |
| 2064 | ERBB2 | C0853897 | Diabetic Cardiomyopathies | 0.08 | RGD |
| 2064 | ERBB2 | C0278488 | Carcinoma breast stage IV | 0.0730773246006846 | BEFREE |
| 2064 | ERBB2 | C0024623 | Malignant neoplasm of stomach | 0.062506681731327 | BEFREE;GAD |
| 2064 | ERBB2 | C0029925 | Ovarian Carcinoma | 0.0510991818636366 | BEFREE |
| 2064 | ERBB2 | C1140680 | Malignant neoplasm of ovary | 0.0476059228491897 | BEFREE;GAD |
| 2064 | ERBB2 | C0242379 | Malignant neoplasm of lung | 0.0438506136962232 | BEFREE;GAD |
| 2064 | ERBB2 | C3539878 | Triple Negative Breast Neoplasms | 0.0428573783372436 | BEFREE |
| 2064 | ERBB2 | C1512127 | HER2 gene amplification | 0.0392859301424733 | BEFREE |
| 2064 | ERBB2 | C0007137 | Squamous cell carcinoma | 0.0358088531787482 | BEFREE;GAD;LHGDN |
| 2064 | ERBB2 | C0853879 | Invasive carcinoma of breast | 0.0258243177160314 | BEFREE |
| 2064 | ERBB2 | C0007124 | Noninfiltrating Intraductal Carcinoma | 0.0255065247998666 | BEFREE;LHGDN |
| 2064 | ERBB2 | C3642345 | Luminal A Breast Carcinoma | 0.0252748641476052 | BEFREE |
| 2064 | ERBB2 | C0376358 | Malignant neoplasm of prostate | 0.0243196587257061 | BEFREE;GAD |
| 2064 | ERBB2 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0236265034423266 | BEFREE |
| 2064 | ERBB2 | C0009404 | Colorectal Neoplasms | 0.0226874800711493 | BEFREE;LHGDN |
| 2064 | ERBB2 | C3642346 | Luminal B Breast Carcinoma | 0.0211539623844087 | BEFREE |
| 2064 | ERBB2 | C0600139 | Prostate carcinoma | 0.0211539623844087 | BEFREE |
| 2064 | ERBB2 | C0686619 | Secondary malignant neoplasm of lymph node | 0.019230874894917 | BEFREE |
| 2064 | ERBB2 | C1176475 | Ductal Carcinoma | 0.0186239998172218 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0178874 | Tumor Progression | 0.0181319677580646 | BEFREE |
| 2064 | ERBB2 | C0005695 | Bladder Neoplasm | 0.0177998194645825 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0677886 | Epithelial ovarian cancer | 0.0177917284392216 | BEFREE;GAD |
| 2064 | ERBB2 | C0684249 | Carcinoma of lung | 0.0167583338369991 | BEFREE |
| 2064 | ERBB2 | C0029463 | Osteosarcoma | 0.0161514587593039 | BEFREE;LHGDN |
| 2064 | ERBB2 | C1306460 | Primary malignant neoplasm of lung | 0.0159341534843598 | BEFREE |
| 2064 | ERBB2 | C0007138 | Carcinoma, Transitional Cell | 0.0145030980540253 | BEFREE;LHGDN |
| 2064 | ERBB2 | C1527249 | Colorectal Cancer | 0.0131213731075989 | BEFREE;GAD |
| 2064 | ERBB2 | C0014170 | Endometrial Neoplasms | 0.0130127944410173 | GAD;LHGDN |
| 2064 | ERBB2 | C0476089 | Endometrial Carcinoma | 0.0125719195391727 | BEFREE;GAD |
| 2064 | ERBB2 | C0005684 | Malignant neoplasm of urinary bladder | 0.0116822266519035 | BEFREE;GAD |
| 2064 | ERBB2 | C0009402 | Colorectal Carcinoma | 0.0107143445843109 | BEFREE |
| 2064 | ERBB2 | C0278601 | Inflammatory Breast Carcinoma | 0.0101648910158847 | BEFREE |
| 2064 | ERBB2 | C1512981 | Mammary Tumorigenesis | 0.0096154374474585 | BEFREE |
| 2064 | ERBB2 | C0220650 | Metastatic malignant neoplasm to brain | 0.0093407106632454 | BEFREE |
| 2064 | ERBB2 | C0025202 | melanoma | 0.00877690171750195 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0699885 | Carcinoma of bladder | 0.0079670767421799 | BEFREE |
| 2064 | ERBB2 | C0346647 | Malignant neoplasm of pancreas | 0.0074176231737537 | BEFREE |
| 2064 | ERBB2 | C1134719 | Invasive Ductal Breast Carcinoma | 0.0074176231737537 | BEFREE |
| 2064 | ERBB2 | C0280100 | solid tumor | 0.0071428963895406 | BEFREE |
| 2064 | ERBB2 | C0026277 | Mixed Salivary Gland Tumor | 0.0071141856349061 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0039101 | synovial sarcoma | 0.0071141856349061 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0235974 | Pancreatic carcinoma | 0.0065934428211144 | BEFREE |
| 2064 | ERBB2 | C2986665 | Early-Stage Breast Carcinoma | 0.0065934428211144 | BEFREE |
| 2064 | ERBB2 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0065934428211144 | BEFREE |
| 2064 | ERBB2 | C0149925 | Small cell carcinoma of lung | 0.00575490709115785 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0030297 | Pancreatic Neoplasm | 0.00568939455652795 | BEFREE;GAD;LHGDN |
| 2064 | ERBB2 | C0040136 | Thyroid Neoplasm | 0.00568939455652795 | BEFREE;GAD;LHGDN |
| 2064 | ERBB2 | C1883486 | Uterine Corpus Cancer | 0.005494535684262 | BEFREE |
| 2064 | ERBB2 | C0546837 | Malignant neoplasm of esophagus | 0.005494535684262 | BEFREE |
| 2064 | ERBB2 | C0003130 | Anoxia | 0.0054658249296275 | LHGDN |
| 2064 | ERBB2 | C0206650 | Fibroadenoma | 0.00541466777231485 | BEFREE;GAD;LHGDN |
| 2064 | ERBB2 | C0007103 | Malignant neoplasm of endometrium | 0.0052198089000489 | BEFREE |
| 2064 | ERBB2 | C0279628 | Adenocarcinoma Of Esophagus | 0.0049450821158358 | BEFREE |
| 2064 | ERBB2 | C0302592 | Cervix carcinoma | 0.0048795695812059 | BEFREE;GAD |
| 2064 | ERBB2 | C0026640 | Mouth Neoplasms | 0.004814057046576 | GAD |
| 2064 | ERBB2 | C0152018 | Esophageal carcinoma | 0.0046703553316227 | BEFREE |
| 2064 | ERBB2 | C0001430 | Adenoma | 0.00465599995430545 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0007133 | Carcinoma, Papillary | 0.00465599995430545 | BEFREE;LHGDN |
| 2064 | ERBB2 | C2239176 | Liver carcinoma | 0.00465599995430545 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0019348 | Herpes Simplex Infections | 0.00465599995430545 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0006118 | Brain Neoplasms | 0.0046048427969928 | BEFREE;GAD |
| 2064 | ERBB2 | C0238033 | Carcinoma of Male Breast | 0.0043956285474096 | BEFREE |
| 2064 | ERBB2 | C0278701 | Gastric Adenocarcinoma | 0.0043956285474096 | BEFREE |
| 2064 | ERBB2 | C0040997 | Trigeminal Neuralgia | 0.0043956285474096 | BEFREE |
| 2064 | ERBB2 | C0242787 | Malignant neoplasm of male breast | 0.0041209017631965 | BEFREE |
| 2064 | ERBB2 | C0585442 | Osteosarcoma of bone | 0.0041209017631965 | BEFREE |
| 2064 | ERBB2 | C0206704 | Carcinoma, Large Cell | 0.00410654638587925 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0028754 | Obesity | 0.0040553892285666 | BEFREE;GAD |
| 2064 | ERBB2 | C0686377 | CNS metastases | 0.0038461749789834 | BEFREE |
| 2064 | ERBB2 | C0035335 | Retinoblastoma | 0.00383181960166615 | BEFREE;LHGDN |
| 2064 | ERBB2 | C1334274 | Invasive Carcinoma | 0.0035714481947703 | BEFREE |
| 2064 | ERBB2 | C0004763 | Barrett Esophagus | 0.0035714481947703 | BEFREE |
| 2064 | ERBB2 | C0027708 | Nephroblastoma | 0.00355709281745305 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0153676 | Secondary malignant neoplasm of lung | 0.0032967214105572 | BEFREE |
| 2064 | ERBB2 | C0206701 | Cystadenocarcinoma, Serous | 0.0032967214105572 | BEFREE |
| 2064 | ERBB2 | C1368683 | Epithelioma | 0.0032967214105572 | BEFREE |
| 2064 | ERBB2 | C1449563 | Cardiomyopathy, Familial Idiopathic | 0.0032967214105572 | BEFREE |
| 2064 | ERBB2 | C0017150 | Gastrinoma | 0.00328236603323995 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0027859 | Acoustic Neuroma | 0.00328236603323995 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0153381 | Malignant neoplasm of mouth | 0.0032312088759273 | BEFREE;GAD |
| 2064 | ERBB2 | C1301194 | Salivary duct carcinoma | 0.0030219946263441 | BEFREE |
| 2064 | ERBB2 | C0007102 | Malignant tumor of colon | 0.0030219946263441 | BEFREE |
| 2064 | ERBB2 | C0279680 | Transitional cell carcinoma of bladder | 0.0030219946263441 | BEFREE |
| 2064 | ERBB2 | C0332996 | Persistent embryonic structure | 0.0030219946263441 | BEFREE |
| 2064 | ERBB2 | C0032927 | Precancerous Conditions | 0.0030219946263441 | BEFREE |
| 2064 | ERBB2 | C0003873 | Rheumatoid Arthritis | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0007193 | Cardiomyopathy, Dilated | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C2937421 | Prostatic Hyperplasia | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0019829 | Hodgkin Disease | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0022680 | Polycystic Kidney Diseases | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0031511 | Pheochromocytoma | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C0034069 | Pulmonary Fibrosis | 0.00300763924902685 | BEFREE;LHGDN |
| 2064 | ERBB2 | C1257930 | Mammary Carcinoma, Human | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C1261473 | Sarcoma | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C0279626 | Squamous cell carcinoma of esophagus | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C0494165 | Secondary malignant neoplasm of liver | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C0521158 | Recurrent tumor | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C0699790 | Colon Carcinoma | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C0858252 | breast adenocarcinoma | 0.002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206727 | Nerve Sheath Tumors | 0.00273291246481375 | LHGDN |
| 2064 | ERBB2 | C0007959 | Charcot-Marie-Tooth Disease | 0.00273291246481375 | LHGDN |
| 2064 | ERBB2 | C0023267 | Fibroid Tumor | 0.00273291246481375 | LHGDN |
| 2064 | ERBB2 | C0032273 | Pneumoconiosis | 0.00273291246481375 | LHGDN |
| 2064 | ERBB2 | C0040411 | Tongue Neoplasms | 0.00273291246481375 | LHGDN |
| 2064 | ERBB2 | C0950124 | Papillomavirus Infections | 0.00273291246481375 | LHGDN |
| 2064 | ERBB2 | C0023055 | Laryngeal neoplasm | 0.0026817553075011 | BEFREE;GAD |
| 2064 | ERBB2 | C0151546 | Oral Cavity Carcinoma | 0.0026817553075011 | BEFREE;GAD |
| 2064 | ERBB2 | C4048328 | cervical cancer | 0.0024725410579179 | BEFREE |
| 2064 | ERBB2 | C0023440 | Acute Erythroblastic Leukemia | 0.0024725410579179 | BEFREE |
| 2064 | ERBB2 | C0007621 | Neoplastic Cell Transformation | 0.002407028523288 | GAD |
| 2064 | ERBB2 | C0018671 | Head and Neck Neoplasms | 0.002407028523288 | GAD |
| 2064 | ERBB2 | C0018799 | Heart Diseases | 0.002407028523288 | GAD |
| 2064 | ERBB2 | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
| 2064 | ERBB2 | C0553723 | Squamous cell carcinoma of skin | 0.002407028523288 | GAD |
| 2064 | ERBB2 | C0031347 | Pharyngeal Neoplasms | 0.002407028523288 | GAD |
| 2064 | ERBB2 | C1709246 | Non-Neoplastic Disorder | 0.0021978142737048 | BEFREE |
| 2064 | ERBB2 | C0278493 | Breast cancer recurrent | 0.0021978142737048 | BEFREE |
| 2064 | ERBB2 | C2145472 | Urothelial Carcinoma | 0.0021978142737048 | BEFREE |
| 2064 | ERBB2 | C0030186 | Paget Disease Extramammary | 0.0021978142737048 | BEFREE |
| 2064 | ERBB2 | C1168401 | Squamous cell carcinoma of the head and neck | 0.0021978142737048 | BEFREE |
| 2064 | ERBB2 | C1275122 | Familial multiple trichoepitheliomata | 0.0019230874894917 | BEFREE |
| 2064 | ERBB2 | C1332460 | Barrett's Adenocarcinoma | 0.0019230874894917 | BEFREE |
| 2064 | ERBB2 | C0221228 | Comedone | 0.0019230874894917 | BEFREE |
| 2064 | ERBB2 | C0007847 | Malignant tumor of cervix | 0.0019230874894917 | BEFREE |
| 2064 | ERBB2 | C0279565 | Invasive Lobular Breast Carcinoma | 0.0019230874894917 | BEFREE |
| 2064 | ERBB2 | C0677898 | invasive cancer | 0.0019230874894917 | BEFREE |
| 2064 | ERBB2 | C0206692 | Carcinoma, Lobular | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C0206694 | Mucoepidermoid Carcinoma | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C0007112 | Adenocarcinoma of prostate | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C0007130 | Mucinous Adenocarcinoma | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C0278498 | Malignant neoplasm of stomach stage IV | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C0344460 | Carcinoma ex pleomorphic adenoma | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C0948380 | Colorectal cancer metastatic | 0.0016483607052786 | BEFREE |
| 2064 | ERBB2 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0235782 | Gallbladder Carcinoma | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C1519670 | Tumor Angiogenesis | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C1519680 | Tumor Immunity | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C1527349 | Ductal Breast Carcinoma | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0007140 | Carcinosarcoma | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C3539781 | Progressive cGVHD | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0281361 | Adenocarcinoma of pancreas | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0023473 | Myeloid Leukemia, Chronic | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0346153 | Breast Cancer, Familial | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0025286 | Meningioma | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0424295 | Hyperactive behavior | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0549473 | Thyroid carcinoma | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0677932 | Progressive Neoplastic Disease | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0685938 | Malignant neoplasm of gastrointestinal tract | 0.0013736339210655 | BEFREE |
| 2064 | ERBB2 | C0153452 | Malignant neoplasm of gallbladder | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0153690 | Secondary malignant neoplasm of bone | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0175754 | Agenesis of corpus callosum | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0206687 | Carcinoma, Endometrioid | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0206693 | Medullary carcinoma | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0220641 | Lip and Oral Cavity Carcinoma | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0220668 | Congenital contractural arachnodactyly | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0235653 | Malignant neoplasm of female breast | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C1511789 | Desmoplastic | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0238198 | Gastrointestinal Stromal Tumors | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0007104 | Female Breast Carcinoma | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0262584 | Carcinoma, Small Cell | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C1704272 | Benign Prostatic Hyperplasia | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0010606 | Adenoid Cystic Carcinoma | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0018802 | Congestive heart failure | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0282160 | Aplasia Cutis Congenita | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0021051 | Immunologic Deficiency Syndromes | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0023418 | leukemia | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0684830 | Secondary malignant neoplasm of axilla | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0750952 | Biliary Tract Cancer | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0854917 | Rhabdoid Tumor of the Kidney | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0085390 | Li-Fraumeni Syndrome | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0936223 | Metastatic Prostate Carcinoma | 0.0010989071368524 | BEFREE |
| 2064 | ERBB2 | C0154084 | Stage 0 Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1332166 | Adenocarcinoma of the Gastroesophageal Junction | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0206685 | Acinar Cell Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0002793 | Anaplasia | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0003504 | Aortic Valve Insufficiency | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0206754 | Neuroendocrine Tumors | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1335475 | Primary Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1336076 | Sporadic Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0004114 | Astrocytoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1402294 | Primary Lesion | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0006413 | Burkitt Lymphoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0238462 | Medullary carcinoma of thyroid | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0007113 | Rectal Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0242596 | Neoplasm, Residual | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1569637 | Adenocarcinoma, Endometrioid | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0265783 | Congenital hypoplasia of lung | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0266999 | Vesicular Stomatitis | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1654637 | androgen independent prostate cancer | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0007682 | CNS disorder | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0278486 | Breast cancer stage II | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1861305 | TARSAL-CARPAL COALITION SYNDROME | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0279671 | Cervical Squamous Cell Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0279672 | Cervical Adenocarcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C3472608 | Micropapillary carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0280630 | Uterine Carcinosarcoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0018801 | Heart failure | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C3642347 | Basal-Like Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C3805278 | Extrahepatic Cholangiocarcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0334359 | Papillary serous cystadenocarcinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0023903 | Liver neoplasms | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0346957 | Disseminated Malignant Neoplasm | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0025007 | Measles | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0027809 | Neurilemmoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0027819 | Neuroblastoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0027831 | Neurofibromatosis 1 | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0553580 | Ewings sarcoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0553665 | Skin endocrine disorder | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0598935 | Tumor Initiation | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0677936 | Refractory cancer | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0032019 | Pituitary Neoplasms | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0033375 | Prolactinoma | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0850666 | helicobacter pylori infection | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0085281 | Addictive Behavior | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0878500 | Intraepithelial Neoplasia | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0085750 | Adenosis of Breast | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C1112160 | Gastrooesophageal cancer | 0.0008241803526393 | BEFREE |
| 2064 | ERBB2 | C0152244 | Bone Cysts, Aneurysmal | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0153567 | Uterine Cancer | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1282496 | Metastasis from malignant tumor of prostate | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0205645 | Adenocarcinoma, Tubular | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1301034 | Pancreatic intraepithelial neoplasia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0206623 | Adenosquamous carcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1328504 | Hormone refractory prostate cancer | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0206629 | Pulmonary Blastoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0206708 | Cervical Intraepithelial Neoplasia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0220636 | Malignant neoplasm of salivary gland | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0004135 | Ataxia Telangiectasia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0004364 | Autoimmune Diseases | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0004565 | Melanoma, B16 | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0220654 | Meningeal Carcinomatosis | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0005967 | Bone neoplasms | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0238122 | Fallopian Tube Carcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0268621 | Hepatic methionine adenosyltransferase deficiency | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1704376 | Uterine Corpus Carcinosarcoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0272138 | Erythroblastosis | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0008479 | Chondrosarcoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1856689 | FRIEDREICH ATAXIA 1 | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0278504 | Non-small cell lung cancer stage I | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1868682 | Paroxysmal kinesigenic choreoathetosis | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0278803 | Adenocarcinoma of small intestine | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0011991 | Diarrhea | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C2348820 | Triple-Negative Breast Carcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0278996 | Cancer of Head and Neck | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0279563 | Lobular carcinoma in situ of breast | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0015625 | Fanconi Anemia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0016034 | Breast Fibrocystic Disease | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0016057 | Fibrosarcoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C3160718 | PARKINSON DISEASE, LATE-ONSET | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0280217 | stage, non-small cell lung cancer | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0018790 | Cardiac Arrest | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0281267 | bilateral breast cancer | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C3549742 | Breast cancer, lobular | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0282612 | Prostatic Intraepithelial Neoplasias | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0334381 | Non-infiltrating lobular carcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0023434 | Chronic Lymphocytic Leukemia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0023487 | Acute Promyelocytic Leukemia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0345905 | Intrahepatic Cholangiocarcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0346429 | Multiple malignancy | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0024299 | Lymphoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0024305 | Lymphoma, Non-Hodgkin | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0346976 | Secondary malignant neoplasm of pancreas | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0026764 | Multiple Myeloma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0027533 | Neck Neoplasms | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0555198 | Malignant Glioma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0555278 | Cerebral metastasis | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0030185 | Paget's Disease, Mammary | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0030421 | Paraganglioma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0677944 | Sentinel node (disorder) | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0678213 | Complete hydatidiform mole | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0700095 | Central neuroblastoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0036095 | Salivary Gland Neoplasms | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0037286 | Skin Neoplasms | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0037579 | Soft Tissue Neoplasms | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0813147 | Stage I Endometrial Carcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0041107 | Trisomy | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0079731 | B-Cell Lymphomas | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0860594 | Malignant melanoma, metastatic | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0862506 | Borderline ovarian tumour | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0878544 | Cardiomyopathies | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0149678 | Epstein-Barr Virus Infections | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1096616 | contralateral breast cancer | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C0149782 | Squamous cell carcinoma of lung | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1135868 | Gestational Trophoblastic Neoplasms | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1153706 | Endometrial adenocarcinoma | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1168327 | High-Grade Prostatic Intraepithelial Neoplasia | 0.0005494535684262 | BEFREE |
| 2064 | ERBB2 | C1257877 | Pheochromocytoma, Extra-Adrenal | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1262091 | Lymphocytic infiltration | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0153574 | Malignant Uterine Corpus Neoplasm | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1263846 | Attention deficit hyperactivity disorder | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0153594 | Malignant neoplasm of testis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1265996 | Large cell neuroendocrine carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0153633 | Malignant neoplasm of brain | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1266042 | Chromophobe Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1266044 | Collecting Duct Carcinoma of the Kidney | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1266129 | Atypical Lipoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1266166 | Intracortical osteosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0162872 | Aortic Aneurysm, Thoracic | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1275217 | Paget's disease of vulva | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1298180 | Single tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0205647 | Follicular adenoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0205696 | Anaplastic carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0205698 | Undifferentiated carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1302773 | Low Grade Squamous Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0205851 | Germ cell tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0205969 | Thymic Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1319315 | Adenocarcinoma of large intestine | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1322286 | Thymoma, type C | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206624 | Hepatoblastoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1332314 | Breast Apocrine Adenosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206655 | Alveolar rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1332316 | Apocrine breast carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206656 | Rhabdomyosarcoma, Embryonal | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1332347 | Atypical Ductal Breast Hyperplasia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206677 | Adenomatous Polyps | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0000768 | Congenital Abnormality | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206681 | Adenocarcinoma, Clear Cell | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1332629 | Breast Fibrocystic Change, Proliferative Type | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0001126 | Renal tubular acidosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206684 | Sebaceous Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1333600 | Hereditary Malignant Neoplasm | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0001339 | Acute pancreatitis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1333791 | Gastric Tubular Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1333990 | Hereditary Nonpolyposis Colorectal Cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0001420 | Papillary adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334015 | High Grade Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334206 | Intermediate Grade Ductal Breast Carcinoma In Situ | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0001442 | Adenosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334272 | Invasive Apocrine Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0002170 | Alopecia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206695 | Carcinoma, Neuroendocrine | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0002726 | Amyloidosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334455 | Pulmonary Sclerosing Hemangioma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0206699 | Cystadenocarcinoma, Mucinous | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334603 | Malignant Mixed Mesodermal (Mullerian) Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0002871 | Anemia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334615 | Malignant Phyllodes Tumor of Prostate | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0002986 | Fabry Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1334708 | Metaplastic breast carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0003175 | Anthrax disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1335409 | Prostate Phyllodes Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0220603 | childhood brain tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1335931 | Breast Sclerosing Adenosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0003886 | Arthrogryposis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0220620 | Gastrointestinal Carcinoid Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1336084 | Squamous Lung Dysplasia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1337013 | Differentiated Thyroid Gland Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1368019 | Paget Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0220656 | Malignant ascites | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1370419 | Granulosa cell tumor of the ovary | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0004997 | Benign Ovarian Neoplasm | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1378703 | Renal carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1384494 | Metastatic Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0235590 | Fibrosing adenosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0005940 | Bone Diseases | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1456781 | Benign melanocytic nevus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1456792 | Still's disease with juvenile onset and/or adult onset | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0006145 | Breast Diseases | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1510885 | Angiogenic Switch | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0238196 | Small intestine carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007095 | Carcinoid Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0238339 | Hereditary pancreatitis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1512409 | Hepatocarcinogenesis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0238348 | Squamous cell carcinoma of penis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0238410 | Renal Pelvis Urothelial Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1514507 | Prostate Basal Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007107 | Malignant neoplasm of larynx | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0238461 | Anaplastic thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1519176 | Salivary Gland Pleomorphic Adenoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1519346 | Skin Carcinogenesis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007114 | Malignant neoplasm of skin | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0259770 | Epithelial inclusion cyst | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0262401 | Carcinoma of ampulla of Vater | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1559154 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1563119 | Hormone receptor positive tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007125 | Carcinoma, Ehrlich Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0264716 | Chronic heart failure | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007129 | Merkel cell carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0266166 | Congenital duplication of intestine | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1623038 | Cirrhosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0267937 | Acute recurrent pancreatitis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1704231 | Metastatic Malignant Neoplasm to the Leptomeninges | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0268070 | Hypocupremia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0268398 | Familial lichen amyloidosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1704323 | Paget's Disease of the Nipple | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0269102 | Endometrioma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1706827 | Carcinoma of apocrine gland | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0270911 | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0007570 | Celiac Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1710096 | Sinonasal undifferentiated carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278485 | Carcinoma breast stage I | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1710547 | Unilateral Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1739363 | Prostatic Hypertrophy | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278487 | Stage III Breast Cancer AJCC v6 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1839163 | THROMBOCYTOPENIA 1 (disorder) | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1851585 | MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0008354 | Cholera | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278489 | Stage IIIA Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1854365 | BREAST CANCER 3 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1855900 | HYPERTRICHOSIS, CONGENITAL GENERALIZED | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0008487 | Chordoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0008626 | Congenital chromosomal disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1859308 | PREMATURE CENTROMERE DIVISION | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278510 | Medulloblastoma, Childhood | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278512 | Metastatic osteosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1861906 | Breast Cancer, Familial Male | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278517 | Non-small cell lung cancer recurrent | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1862382 | SVEINSSON CHORIORETINAL ATROPHY | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278562 | Esophageal neoplasm metastatic | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1866260 | Peroxisome Biogenesis Disorder, Complementation Group H | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0010631 | Cystadenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0010633 | Cystadenoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0010692 | Cystitis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278704 | Malignant Childhood Neoplasm | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1960398 | HER2-positive carcinoma of breast | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0010701 | Phyllodes Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278798 | Endometrial neoplasm malignant stage I | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1960925 | Epidermal growth factor receptor positive non-small cell lung cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0011119 | Decompression Sickness | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278802 | Recurrent Endometrial Cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0011848 | Diabetes Insipidus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2187547 | Retroperitoneal Leiomyosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278828 | Stage IV Bladder Cancer AJCC v6 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2216695 | malignant neoplasm of breast stage I | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0013080 | Down Syndrome | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278838 | Prostate cancer recurrent | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0013274 | Patent ductus arteriosus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0278883 | Metastatic melanoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0014132 | Endocrine Gland Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2363129 | Benign Rolandic Epilepsy | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2717836 | Steroid Sulfatase Deficiency Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0014175 | Endometriosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0279557 | Adenosquamous cell lung cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2919327 | Pleomorphic lobular carcinoma in situ | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2930879 | Cerebellar degeneration, subacute | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2931258 | Amaurosis congenita of Leber, type 1 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0015230 | Exanthema | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C2931852 | Clear-cell metastatic renal cell carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0279633 | intestinal adenocarcinoma of the stomach | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0016977 | Gall Bladder Diseases | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3146271 | Stage III Breast Cancer AJCC v7 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0279746 | Adenocarcinoma of salivary gland | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3249875 | Laryngopharyngeal Cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3250443 | MYOTONIC DYSTROPHY 1 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3272409 | Gastric Neuroendocrine Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0280253 | stage, gastric cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3463897 | HYDATIDIFORM MOLE, RECURRENT, 1 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0017658 | Glomerulonephritis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0280255 | stage, endometrial cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0018206 | granulosa cell tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0280313 | Squamous cell carcinoma of oropharynx | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0280324 | Laryngeal Squamous Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3489398 | Neuroepithelioma, Peripheral | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0280631 | Leiomyosarcoma of uterus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0018923 | Hemangiosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0019163 | Hepatitis B | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0019340 | herpes | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0302180 | Condyloma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3669246 | Mammary adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3714948 | PACHYONYCHIA CONGENITA 3 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0020217 | Hydatidiform Mole | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0333516 | Tumor necrosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3809250 | ESTROGEN RESISTANCE | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0020459 | Hyperinsulinism | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0333875 | High-Grade Squamous Intraepithelial Lesions | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3839524 | Anemia in malignant neoplastic disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334050 | Adenosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C3887461 | Head and Neck Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0021367 | Mammary Ductal Carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334121 | Inflammatory Myofibroblastic Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0021670 | insulinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334254 | Lymphoepithelial carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C4018978 | Unilateral Breast Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0021841 | Intestinal Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334274 | Papillary transitional cell carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0022521 | Kartagener Syndrome | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334277 | Adenocarcinoma, metastatic | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0022665 | Kidney Neoplasm | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334287 | Fibrolamellar hepatocellular carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C4050504 | Ectomesenchymal Chondromyxoid Tumor | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334299 | Carcinoid tumor no ICD-O subtype | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334355 | Serous cystadenoma, borderline malignancy | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0023343 | Leprosy | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334371 | Secretory breast carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334385 | Inflammatory carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334520 | Teratoma, Malignant | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0023443 | Hairy Cell Leukemia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0334583 | Pilocytic Astrocytoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0023449 | Acute lymphocytic leukemia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0338113 | Uterine Corpus Sarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0023467 | Leukemia, Myelocytic, Acute | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0341823 | Epithelial tumor of ovary | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0343641 | Human papilloma virus infection | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0023890 | Liver Cirrhosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0345904 | Malignant neoplasm of liver | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0346163 | Endometrioid carcinoma ovary | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0024131 | Lupus Vulgaris | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0346300 | Pituitary carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0024138 | Lupus Erythematosus, Discoid | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0024141 | Lupus Erythematosus, Systemic | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0346627 | Intestinal Cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0024143 | Lupus Nephritis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0346629 | Malignant neoplasm of large intestine | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0024314 | Lymphoproliferative Disorders | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0346979 | Secondary malignant neoplasm of bone marrow | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0349530 | Early gastric cancer | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0349782 | Ischemic cardiomyopathy | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0374997 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0376545 | Hematologic Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0392514 | Hereditary hemochromatosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0393534 | Paraneoplastic Cerebellar Degeneration | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0409974 | Lupus Erythematosus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0432412 | Chromosome 8, trisomy | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0026837 | Muscle Rigidity | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0027439 | Nasopharyngeal Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0476147 | Chondrogenic Neoplasm | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0520463 | Chronic active hepatitis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0521857 | Increased drug resistance | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0524851 | Neurodegenerative Disorders | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0027766 | Nervous System Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0027960 | Nevus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0553694 | Oropharyngeal disorders | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0027962 | Melanocytic nevus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0029172 | Oral Submucous Fibrosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0029401 | Osteitis Deformans | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0029408 | Degenerative polyarthritis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0585474 | Ewing's sarcoma of bone | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0029456 | Osteoporosis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0598608 | Hyperhomocysteinemia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0029927 | Ovarian Cysts | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0600041 | Infective cystitis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0029928 | Ovarian Diseases | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0677607 | Hashimoto Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0677776 | Hereditary Breast and Ovarian Cancer Syndrome | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0030193 | Pain | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0030472 | Paraneoplastic Syndromes | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0031039 | Pericardial effusion | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0032002 | Pituitary Diseases | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0684337 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0032320 | Pneumoperitoneum | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0032580 | Adenomatous Polyposis Coli | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0032584 | polyps | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0740277 | Bile duct carcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0034341 | Pyruvate Carboxylase Deficiency Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0740457 | Malignant neoplasm of kidney | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0741923 | cardiac event | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0035412 | Rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0742597 | colon (non-specific) lesion | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0036323 | Schistosomiasis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0751036 | Hereditary Motor and Sensory Neuropathy Type I | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0036920 | Sezary Syndrome | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0751571 | Cancer of Urinary Tract | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0751606 | Adult Acute Lymphocytic Leukemia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0751913 | Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0039483 | Giant Cell Arteritis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0795796 | Chromosome 1, monosomy 1p | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0040100 | Thymoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0795864 | Smith-Magenis syndrome | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0795878 | Monosomy 22 | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0040147 | Thyroiditis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0848332 | Spots on skin | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0851887 | Adenoviral infections | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0041671 | Attention Deficit Disorder | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0042214 | Vaccinia | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0042769 | Virus Diseases | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0079588 | Ichthyosis, X-Linked | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0854988 | Adenocarcinoma of lung, stage IV | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0085106 | Familial benign pemphigus | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0860580 | Medullary carcinoma of breast | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0085110 | Severe Combined Immunodeficiency | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0085136 | Central Nervous System Neoplasms | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0085413 | Polycystic Kidney, Autosomal Dominant | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0085695 | Chronic gastritis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0920350 | Autoimmune thyroiditis | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0086025 | Codependency | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0948216 | ovarian adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0087031 | Juvenile-Onset Still Disease | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0149521 | Pancreatitis, Chronic | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0149826 | Gastric adenoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0151468 | Thyroid Gland Follicular Adenoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0151514 | Atrophic condition of skin | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C1142347 | Stage IV Esophageal Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2064 | ERBB2 | C0151744 | Myocardial Ischemia | 0.0002747267842131 | BEFREE |